Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
N/A
-22,968 Reduced 69.18%
10,232 $50,000
Q4 2023

Oct 21, 2024

BUY
N/A
13,883 Added 71.87%
33,200 $164,000
Q4 2023

Feb 07, 2024

BUY
N/A
33,200 New
33,200 $164,000
Q1 2023

Oct 21, 2024

BUY
$4.13 - $6.27 $79,779 - $121,117
19,317 New
19,317 $106,000
Q1 2023

May 03, 2023

BUY
$4.13 - $6.27 $6,405 - $9,724
1,551 Added 8.73%
19,317 $106,000
Q4 2022

Feb 13, 2023

BUY
$4.12 - $5.62 $73,195 - $99,844
17,766 New
17,766 $81,000
Q2 2022

Aug 09, 2022

BUY
$4.02 - $5.21 $132,414 - $171,612
32,939 New
32,939 $147,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.